Spectris Dividends - SXS

Spectris Dividends - SXS

Best deals to access real time data!
Silver
Monthly Subscription
for only
£17.37
Level 2 Basic
Monthly Subscription
for only
£62.08
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Spectris Plc SXS London Ordinary Share GB0003308607 ORD 5P
  Price Change Price Change % Stock Price High Price Low Price Open Price Close Price Last Trade
  -15.00 -0.66% 2,260.00 2,308.00 2,258.00 2,282.00 2,275.00 16:29:29
more quote information »
Industry Sector
ELECTRONIC & ELECTRICAL EQUIPMENT

Spectris SXS Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
30/07/2019InterimGBX21.931/12/201831/12/201910/10/201911/10/201908/11/20190
19/02/2019FinalGBX40.531/12/201731/12/201823/05/201924/05/201928/06/201961
24/07/2018InterimGBX20.531/12/201731/12/201811/10/201812/10/201809/11/20180
19/02/2018FinalGBX37.531/12/201631/12/201724/05/201825/05/201829/06/201856.5
25/07/2017InterimGBX1931/12/201631/12/201712/10/201713/10/201710/11/20170
14/02/2017FinalGBX3431/12/201531/12/201625/05/201726/05/201730/06/201752
28/07/2016InterimGBX1831/12/201531/12/201613/10/201614/10/201611/11/20160
16/02/2016FinalGBX32.231/12/201431/12/201525/05/201626/05/201624/06/201649.5
30/07/2015InterimGBX17.331/12/201431/12/201515/10/201516/10/201513/11/20150
27/02/2015FinalGBX30.7531/12/201331/12/201428/05/201529/05/201526/06/201546.75
25/07/2014InterimGBX1631/12/201331/12/201415/10/201417/10/201412/11/20140
27/02/2014FinalGBX2831/12/201231/12/201328/05/201430/05/201425/06/201442.75
26/07/2013InterimGBX14.7531/12/201231/12/201316/10/201318/10/201308/11/20130
20/02/2013FinalGBX25.531/12/201131/12/201229/05/201331/05/201326/06/201339
27/07/2012InterimGBX13.531/12/201131/12/201217/10/201219/10/201209/11/20120
17/02/2012FinalGBX25.431/12/201031/12/201130/05/201201/06/201226/06/201233.6
23/08/2011InterimGBX8.231/12/201031/12/201119/10/201121/10/201111/11/20110
25/02/2011FinalGBX20.931/12/200931/12/201001/06/201103/06/201124/06/201128
24/08/2010InterimGBX7.131/12/200931/12/201020/10/201022/10/201012/11/20100
23/02/2010FinalGBX17.8531/12/200831/12/200902/06/201004/06/201025/06/201024.25
25/08/2009InterimGBX6.430/12/200830/06/200921/10/200923/10/200913/11/20090
24/02/2009FinalGBX1731/12/200731/12/200803/06/200905/06/200926/06/200923.4
22/08/2008InterimGBX6.430/12/200730/06/200822/10/200824/10/200814/11/20080
22/02/2008FinalGBX15.7531/12/200631/12/200728/05/200830/05/200820/06/200821
24/08/2007InterimGBX5.7530/12/200630/06/200724/10/200726/10/200716/11/20070
25/02/2007FinalGBX12.531/12/200531/12/200630/05/200701/06/200722/06/200717.5
05/09/2006InterimGBX530/12/200530/06/200618/10/200620/10/200617/11/20060
07/03/2006FinalGBX11.231/12/200431/12/200531/05/200602/06/200623/06/200615.8
13/09/2005InterimGBX4.630/12/200430/06/200519/10/200521/10/200518/11/20050
15/03/2005FinalGBX10.2531/12/200331/12/200418/05/200520/05/200510/06/200514.5
14/09/2004InterimGBX4.2530/12/200330/06/200420/10/200422/10/200419/11/20040
16/03/2004FinalGBX9.331/12/200231/12/200319/05/200421/05/200411/06/200413.35
09/09/2003InterimGBX4.0530/12/200230/06/200315/10/200317/10/200314/11/20030
11/03/2003FinalGBX8.8531/12/200131/12/200214/05/200316/05/200313/06/200312.75
09/09/2002InterimGBX3.930/12/200130/06/200216/10/200218/10/200215/11/20020
11/03/2002FinalGBX8.531/12/200031/12/200115/05/200217/05/200214/06/200212.25
10/09/2001InterimGBX3.7530/12/200030/06/200117/10/200119/10/200116/11/20010
12/03/2001FinalGBX8.1531/12/199931/12/200016/05/200118/05/200115/06/200111.7
11/09/2000InterimGBX3.5530/12/199930/06/200016/10/200020/10/200015/11/20000
13/03/2000FinalGBX7.6531/12/199831/12/199915/05/200019/05/200016/06/200011
13/09/1999InterimGBX3.3503/01/199903/07/199911/10/199915/10/199912/11/19990
15/03/1999FinalGBX7.331/12/199731/12/199817/05/199921/05/199918/06/199910.5
14/09/1998InterimGBX3.204/01/199804/07/199812/10/199816/10/199813/11/19980
16/03/1998FinalGBX6.9531/12/199631/12/199711/05/199815/05/199812/06/199810

Top Dividend Posts

DateSubject
30/8/2016
10:20
iwilllosemyshirt: REDS, remarkable recovery story not yet well known. Trading update 5th September. REDS provides software applications for smart buildings and counts pharmaceutical giant GlaxoSmithKline and real estate player Meyer Bergman among its customers. Constant flow of new contracts with large multinationals. They got recently a 12 million contract with UBS which represented 50% of REDS' market capital! UBS have 700 more branches needing possibly the same service. New CEO Mark Braund very positive and invested his own money along with the financial director. Mark is a specialist in turning around struggling companies. He has already done it with REDS in less than a year. http://uk.advfn.com/stock-market/london/redstoneconnect-plc-REDS/share-price?java=1 http://uk.advfn.com/news/share/LSE%3AREDS hxxp://www.channelweb.co.uk/crn-uk/news/2451217/redstone-shrugging-off-baggage-of-the-past-with-connect-ib-deal
23/1/2015
19:44
jeffcranbounre: Spectris is featured in today's ADVFN podcast. You can listen to the podcast by clicking here> http://bit.ly/ADVFN0114 In today's podcast: - Technical Analyst and PR at Materinvestor.co.uk Zak Mir chatting and charting Quindell, Gulf Keystone Petroleum, Tesco, Royal Mail, Anite and Blur. Zak on Twitter is @ZaksTradingCafe - The micro and macro news - Plus the broker forecasts   Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below. Ten Bagger Tuesday (All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below: Suggest a stock (Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). You can subscribe to this podcast in iTunes by clicking HERE To follow me on Twitter click HERE As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions: Bronze - £50 (normally £73.82/year) Silver - £145 (normally £173.71/year) Level 2 - £350 (normally £472.94/year) Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information. Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing. Justin    
28/4/2013
08:29
roger-lawson: Regarding the share price fall after the announcement on the 19th, I listened into the analysts conference call that morning and then attended the AGM later in the day. The information gleaned from those two events helps to explain why there was a bit of a rebound in the price subsequently. A full report of the conference call and the AGM is present on the ShareSoc Members Network here: http://sharesoc.ning.com/forum/topics/the-agm-forum?commentId=6389471%3AComment%3A22382 (but you need to sign up as a free member of ShareSoc to access the document, which you can do from here: www.sharesoc.org/membership.html I don't know why more people don't attend AGMs. I learned quite a lot from doing so in this case. We publish a lot of reports on AGMs as an information resource for members. Roger Lawson, ShareSoc
23/4/2013
16:25
broadwood: Following a sharp fall in the share price of instrumentation and controls company Spectris on Friday after its first-quarter trading update, Investec has upgraded the stock from 'hold' to 'buy'. The stock slumped by over 15% from 2,225p on Thursday's close (before the statement) to just 1,880p by Monday's close after the firm reported a decline in sales on Friday due to a deferral of orders and shipment delays. Analyst Michael Blogg said: "Spectris rarely scares investors and, arguably, the reaction to Friday's update has been excessive. The 9.0% revenue decline in Q1 arose from a combination of challenging comparisons with strong trading a year earlier, delivery phasing that was either pre-arranged or caused by slippage into Q2, and a disappointing tendency among customers to conserve cash." Nevertheless, he said: "Spectris does not quantify or guide on quarterly revenues, only the H1:H2 bias, and we sense that it was less surprised at a year-on-year decline in Q1 than we were and more confident of a bounce in Q2, with its knowledge of the contributory elements." Investec has cut its annual earnings forecasts by a precautionary 5.0% on 2.2% lower revenues. The target price has come down to 2,330p, from 2,575p previously due to reduced earnings estimates and the de-rating of peers. The stock rebounded strongly on Tuesday, trading 6.86% higher at 2,009p before the close of trade. BC
11/4/2013
10:32
broadwood: pearl - well done. Share price running up ahead of IMS.
13/2/2013
15:35
broadwood: The higher the share price, the lower the yield becomes. But whose complaining. Certainly its been comprehensively re-rated.
30/9/2010
19:58
sharw: Yet another new intra-day high and closing high. I am starting to wonder if there will be an announcement starting with the usual "the company has noted the move in its share price...".
13/2/2004
12:50
campbed: Certainly surprises me to see SXS at 500p so far in advance of results and outperforming Halma, Kidde, Renishaw, and other electronic control 250 stocks. Recent broker forecasts look to slightly reduce consensus for 2003 EBTAEx to £48.5m though adj EPS is up slightly to 30.5p on company's indication of lower tax charge. That's still a trailing PER of 16.4 at 500p with only around 10% growth for 2004. Also they've increased goodwill on 2003 on PANanalytical acquistion completed in Sept 02 (see post 51 above) but doubt that will get any mention in the prelims and we will have to await R&A to read about that. SXS share price does seem to have a history of overshooting on upside as with many Caz brokered stocks and so, particularly in this market that is currently wanting to hear good news on anything techie, I'm continuing to sit on the sidelines for the moment awaiting the results.
11/9/2003
17:08
campbed: I seem to be the only one trying to make sense of SXS's results. I'll give my views this time but unless there is some worthwhile feedback from others then I will not bother again in future. Aixam's spam above also turns me off posting. I shorted Tuesday first thing upon seeing the interims. I have a target of 400p on unchanged market sentiment with a guaranteed stop loss at 510p to offer protection against a bid. The number that leapt out at me from the interims was the free cash flow (FCF). At only £2.2.m this was even less than the £2.9m in H1 last year despite having PANanalytical this H1 (bought for £96.1m last September). Spending against other provision/liabilities was £2.1m this H1 against £6.8m last H1 and adding this spending back gives comparables of £4.3m against £9.7m last H1. SXS look again to have been playing the acquisition accounting game. Goodwill in the balance sheet has increased by £8.8m when there were no acquistions in H1 (from £213.6m at 31 Dec to £222.4m) despite a goodwill amortisation charge of £6.2m in H1. Hence additional goodwill of some £15m has been created presumably on the PANanalytical acquisition made last September for £96.1m. In the Dec 2002 accounts SXS had assigned only £14.1m to fair value of the tangible net assets acquired (including £3.1m of cash) and so created £82m goodwill. If the £15m additional goodwill created does relate just to PANanalytical then SXS will have paid £93m net of cash acquired for no tangible net assets. The concern of course is that the new debit to goodwill would otherwise have been accounted for as losses. With about 123.7m shares, SXS's mkt cap at 490p is £606m. Net debt increased £14m to £191.5m at June. Hence enterprise value (EV) of about £800m. To the FCF of £2.2m add back £2.1m of "exceptional spending" and net interest paid of £5.2m to get A(djusted) FCF of £9.5m. Hence SXS cash generation earned 9.5/800 = 1.2% in H1 or about 2.5% annualised after tax. I just can't see SXS generating AFCF of £80m per year in the near future to justify an EV of £800m. A fairer price in today's market IMO is around 330p to give an EV of about £600m. This gives an EBITA/EV of about 10% based on forecasted EBTA (PBT) of £50m and £10m interest. SXS's share price has had a good run to almost 500p, having roughly doubled from the 230p low last October and in my view has simply overshot. However SXS is well supported by institutions and its retail following is insignificant. For long holders, other shares offer much better value IMO.
12/6/2003
10:39
campbed: mattharop – I think you're wise to abandon your short on SXS for the time being dolphinspirit- SXS' share price could in my view easily go to £4.50 if markets continue to look for recovery and warm noises keep emanating from management as I’m told they did at last week's institutional meeting. £5 would be pushing it but, as we saw in the last few days with M&B, Cazenove can often be particularly effective at gaining “recognition” for the price of their clients' shares. ldrcvem - glad your T+20 sell (or whatever) on Marconi worked. As to Regus, there is not a normal market in its shares at the moment because Indigo has gone long on CFD's through Cantor on most of the free float. GNI has a disclosable holding. They are squeezing the bears. This is not a market for “country”; members who are not in the know. Hence I have no position while the inside bulls & bears tussle. Jeffian on the Advfn bb is right IMO that Regus' shares on fundamental analysis is worth very little. As to why Indigo is doing this is a matter for conjecture but, as Maxwell showed, if a company is fundamentally bust then the value of its shares can only be supported for so long before the inevitable happens. LMC just appears to be a fashion frenzy and/or hopes of a US acquirer -- it was up another 12.5p today to 162.5p and up another 7p today in a sea of blue following New York. As to Spectris (SXS), although it is a FTSE 250 share it does not have much retail following. Hence no attendees at the recent AGM of SXS; though the company secretary does not seem to be disappointed by this. It makes me think about buying a token share in certificated form just to attend next year’s AGM to give them a surprise. I think company secretaries/directors/pr/brokers should monitor Advfn BB's for retail feedback and believe that happens more often than you'd expect. However they cannot say much, if anything. It was therefore good to see Roger Stephens, SXS company secretary, break cover at post #19 and wittily pull me up for being allegorical. However I note that JeremyL who posted as an employee of a trading company within the Spectris group on the last thread has not been heard from recently and has presumably been told not to post by the good Mr Stephens. Go on JeremyL prove me wrong!! In summary, there are currently shares other than SXS on which with more assurance one can go either long or short: hence I’ve no position.
Your Recent History
LSE
SXS
Spectris
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191017 20:43:20